J. Clin. Invest. https://doi.org/10.1172/JCI126595 (2019)
The rate of loss of beta cells in type 1 diabetes (T1D) can be highly variable between patients. In the Journal of Clinical Investigation, Long and colleagues use mass cytometry to deep-phenotype islet-specific CD8+ T cells from patients with T1D and healthy controls in order to understand whether these cells — which are known drivers of T1D — influence the rate of loss of residual beta cell mass. Patients with T1D were stratified into ‘slow’ or ‘rapid’ progressors depending on the rate of C-peptide loss. Interestingly, slow and rapid progressors and even healthy controls showed equivalent frequencies of islet-reactive CD8+ T cells in peripheral blood; however, the phenotype of the CD8+ T cells clearly differed. Specifically, slow progressors’ cells showed an exhausted phenotype and were poorly responsive in vitro, whereas rapid progressors’ CD8+ T cells had an activated phenotype. CD8+ T cell phenotype may thus represent a useful biomarker to predict the progression of T1D.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fehervari, Z. The benefits of exhaustion. Nat Immunol 21, 103 (2020). https://doi.org/10.1038/s41590-020-0590-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-020-0590-z